To ask the Secretary of State for Health
(1) what steps her Department plans to take to ensure that Glockhardt UK passes its technology to another manufacturer in order to guarantee continuity of supply of animal insulins, as discussed at the meeting between Department of Health officials and key stakeholders on 17 May 2006; and if she will make a statement;
(2) what her Department's strategy is for the supply of animal insulin; when it was published; and if she will place a copy of the strategy in the Library.
To ask the Secretary of State for Health pursuant to her letter to the hon. Member for Bromley and Chislehurst (Robert Neill), dated 28 November 2006, and her letter to Earl Howe dated 10 July 2006, what her Department's insulin strategy is; when it was published; if she will place a copy of the strategy in the Library; and if she will make a statement.
The Department has received assurances from Wockhardt UK that if at any time in the future it decided to cease supply of its animal insulins, it would actively support another manufacturer with its licence application, sharing licence data to support it coming into the market to the best of its ability. The Department will support and facilitate this process.
The Department's strategy for the supply of animal insulins has been placed in the Library.